Literature DB >> 1782415

Role of mucus in gastric mucosal protection.

B L Slomiany1, A Slomiany.   

Abstract

Even though there is no general agreement as to the mechanism of gastric mucosal protection, the consensus is that the initial brunt of luminal insults falls on the mucus layer which constitutes the only identifiable physical barrier between the gastric lumen and the mucosal surface. The continuous renewal and resilient nature of this layer efficiently counters peptic erosion of the gel, assures its viscoelastic and permselective properties, and provides a milieu for containment of the diffusing luminal acid by mucosal bicarbonate. Disturbances in this delicate balance lead to the impairment of the protective function of mucus resulting in gastric disease. Indeed, the weakening of gastric mucosal defense is intimately associated with the diminished viscoelastic qualities of mucus, decrease in hydrogen ion retardation capacity, and the extensive proteolysis of its mucin component. Although until recently the disintegration of the mucus coat was attributed exclusively to the enhanced activity of intragastric pepsin, our studies provided strong argument that a bacterial factor, namely infection by Helicobacter pylori, through the action of its protease and lipase enzymes also is highly detrimental to the integrity of gastric mucus. Hence, agents capable of interfering with the pathogenic activity of this bacteria are becoming the drugs of choice in peptic ulcer therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782415

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  8 in total

1.  Disruption of the mucus barrier by topically applied exogenous particles.

Authors:  Shayna L McGill; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2010-10-15       Impact factor: 4.939

2.  Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development.

Authors:  Leandro Honorato; Jhon Jhamilton Artunduaga Bonilla; Alicia C Piffer; Leonardo Nimrichter
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

3.  Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies.

Authors:  A Ottlecz; J J Romero; S L Hazell; D Y Graham; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

4.  Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis.

Authors:  Ma Jinfeng; Wataru Kimura; Ichiro Hirai; Fumiaki Sakurai; Toshiyuki Moriya; Masaomi Mizutani
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 5.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

6.  Peroxisome proliferator-activated receptor gamma activation counters the detrimental effect of Helicobacter pylori lipopolysaccharide on gastric mucin synthesis.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

7.  Protective effect of D-002, a mixture of beeswax alcohols, against indomethacin-induced gastric ulcers and mechanism of action.

Authors:  Yohani Pérez; Ambar Oyárzabal; Rosa Mas; Vivian Molina; Sonia Jiménez
Journal:  J Nat Med       Date:  2012-05-11       Impact factor: 2.343

8.  Development and evaluation of pharmacosomes of aceclofenac.

Authors:  A Semalty; Mona Semalty; B S Rawat; D Singh; M S M Rawat
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.